Family and Childrens Place

If you are looking at Family and Childrens Place in Philadelphia, PA, the basics worth knowing up front: The specific care levels offered by Family and Childrens Place should be confirmed directly with the admissions team. This page walks through the questions that tend to matter most to families weighing a specific program.

Care levels at Family and Childrens Place

On care levels specifically: Care-level specifics for Family and Childrens Place are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. What that means in practice is that matching Family and Childrens Place to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

On insurance specifically: Payment and insurance specifics for Family and Childrens Place are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Family and Childrens Place offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Programs that cannot answer all three quickly are programs worth approaching with caution.